Session Details
[P1-12]Genetic Counseling 1
Thu. Nov 19, 2026 4:00 PM - 5:00 PM JST
Thu. Nov 19, 2026 7:00 AM - 8:00 AM UTC
Thu. Nov 19, 2026 7:00 AM - 8:00 AM UTC
Exhibition Hall 1-A+2 (12) (Exhibition Hall 1-A+2, Exhibition Building, Sendai International Center)
[P1-12-01]HBOC Management in Collaboration with Certified Genetic Counselors.
Noriko Abe1,2, Reimi Sogawa2, Yumi Takakura2, Miki Yonamine2, Mayumi Ikeuchi1, Reina Yajima1, Uiko Hanaoka2,3, Kensuke Kumamoto2,4 (1. Breast and Endocrine Surgery, Kagawa University Hospital, Takamatu, Japan, 2. Clinical Genetics and Genomic Medicine, Kagawa University Hospital, Takamatu, Japan, 3. Perinatology and Gynecology, Kagawa University Faculty of Medicine, Takamatu, Japan, 4. Genome Medical Science and Medical Genetics, Takamatu, Japan)
[P1-12-02]Genetic counseling dilemmas in 46, XY DSD with diagnostic uncertainty: three cases initially suspected as AIS
Emi Yokoyama, Masahito Tachibana, Miki Takezawa, Yuki Takahashi, Takeki Sato, Yuri Takahashi, Tsukasa Takahashi, Zen Watanabe, Masatoshi Saito (Department of Obstetrics and Gynecology, Tohoku University, Miyagi, Japan)
[P1-12-03]Importance of Hereditary Cancer Assessment in Oncofertility Care: A Case of Sperm Cryopreservation in Lynch Syndrome
Yutaka Iwaki, Taishi Hamaguchi, Mika Oyaizu, Toshiaki Endo, Hirofumi Henmi (Clinical Genetics Center, Department of Gynecology and Reproductive Endocrinology, Tonan Hospital)
[P1-12-04]Genetic Counseling for a Family with Hypermobile Ehlers-Danlos Syndrome and Mast Cell Activation Syndrome
Maki Taniguchi1, Naoya Morisada1,2 (1. Genome Medical Center, Hyogo Prefectural Kobe Children's Hospital, Kobe, Japan, 2. Department of Clinical Genetics, Hyogo Prefectural Kobe Children's Hospital, Kobe, Japan)
[P1-12-05]Genetic Counseling and Confirmatory Testing Uptake Following Comprehensive Genomic Profiling: A Process Evaluation
Takanobu Shimada1, Noriko Akimaru2, Takehiko Tsumura1, Shogo Yamamura1, Soma Sugimoto1, Shigeru Tsuyuki2, Hiroki Tado3, Takanori Sakurai3, Kazunori Imada4, Takeshi Nakajima5, Shinji Kosugi6, Masashi Kanai7, Masahiro Yoshioka8,9, Keita Fukuyama10, Manabu Muto9 (1. Department of Medical Oncology, Japanese Red Cross Osaka Hospital, 2. Department of Breast Surgery, Japanese Red Cross Osaka Hospital, 3. Department of Diagnostic Pathology, Japanese Red Cross Osaka Hospital, 4. Cancer Treatment Center, Japanese Red Cross Osaka Hospital, 5. Department of Genetic Oncology, Division of Hereditary Tumors, 6. Department of Genomic Medicine, Kyoto University School of Public Health, 7. Department of Clinical Oncology, Kansai Medical University Hospital, 8. Department of Clinical Oncology, Kobe City Nishi-Kobe Medical Center, 9. Department of Therapeutic Oncology, Kyoto University Graduate School of Medicine, 10. Division of Medical Information Technology and Administration Planning, Kyoto University Hospital)
[P1-12-06]Beyond the known familial variant: A dilemma in HBOC cascade testing in a BRCA1/2 double-heterozygous case
Mizuki Takenonaka1, Hiroaki Niitsu1, Hikaru Nakahara1, Akiko Abe1,2, Misako Ishihara1,2, Takao Hinoi1 (1. Department of Clinical and Molecular Genetics, Hiroshima University Hospital, Hiroshima University, Hiroshima, Japan, 2. Department of Nursing, Hiroshima University Hospital, Hiroshima University, Hiroshima, Japan)
[P1-12-07]Assessment of the uptake of genetic testing for hereditary hemorrhagic telangiectasia (HHT) in Mie Prefecture
Takumi Fujiwara1,2, Yoshinaga Okugawa1, Takahito Kitajima1, Ryo Hanaki1, Ryotaro Hashizume1, Hiroshi Imai1, Ikuyo Mochiki1, Kaname Nakatani1, Tetsu Kobayashi2 (1. Department of Genomic Medicine, Mie University Hospital, Mie, Japan, 2. Department of Pulmonary and Critical Care Medicine, Mie University Faculty and Graduate School of Medicine, Mie, Japan)
[P1-12-08]Living with von Hippel-Lindau syndrome (VHL): A qualitative study of family members with VHL
Masako Torishima1,2,3, Manami Matsukawa4,5, Sayoko Haruyama3, Takeshi Nakajima3,6, Ayako Takahashi3,7 (1. Department of Genomic Medicine, Graduate School of Medicine, Kyoto University, 2. VHL Center, Kyoto University Hospital, 3. Clinical Genetics Unit, Kyoto University Hospital, 4. Department of Medical Ethics, Graduate School of Medicine, Kyoto University, 5. Department of Genetic Medicine and Services, National Cancer Center Hospital, 6. Department of Genetic Oncology, Osaka International Cancer Institute, 7. Department of Ophthalmology and Visual Sciences, Graduate School of Medicine, Kyoto University)
[P1-12-09]Genetic counseling for a patient with somatic BRAF V600E-mutated colorectal cancer harboring a pathogenic MLH1 variant
Yuka Wada1,2, Takagi Aya1, Takabayashi Naoki1,2, Kurebayashi Fumi1,2, Yasue Horiuchi1,3, Michiko Tsuneizumi1, Masashi Harazaki1, Rieko Kosugi1, Masayo Ukita1, Yuji Kanazawa1, Hiroyuki Ariyasu1, Takeshi Usui1,3 (1. Department of Medical Genetics, Shizuoka General Hospital, 2. Department of Medical Genetics, Shizuoka Childrens Hospital, 3. Graduate School of Public Health, Shizuoka Graduate University of Public Health)
[P1-12-10]A Case of Fetal Multiple Congenital Anomalies Evaluated by Genomic Autopsy
Aya Yamazaki1, Mariko Ueno2, Akira Nakabayashi2, Toshiyuki Yamamoto3 (1. Tokyo Women's Medical University Adachi Medical Center, 2. Department of Obstetrics and Gynecology, Tokyo Women's Medical University, 3. Institute of Medical Genetics, Tokyo Women's Medical University)
